Predicting bioactivity of antibiotic metabolites by molecular docking and dynamics
H. Chio, E. E. Guest, J. L. Hobman, T. Dottorini, J. D. Hirst, D. J. Stekel
Abstract
Antibiotics enter the environment through waste streams, where they can exert selective pressure for antimicrobial resistance in bacteria. However, many antibiotics are excreted as partly metabolized forms, or can be subject to partial breakdown in wastewater treatment, soil, or through natural processes in the environment. If a metabolite is bioactive, even at sub-lethal levels, and also stable in the environment, then it could provide selection pressure for resistance. (5S)-penicilloic acid of piperacillin has previously been found complexed to the binding pocket of penicillin binding protein 3 (PBP3) of Pseudomonas aeruginosa. Here, we predicted the affinities of all potentially relevant antibiotic metabolites of ten different penicillins to that target protein, using molecular docking and molecular dynamics simulations. Docking predicts that, in addition to penicilloic acid, pseudopenicillin derivatives of these penicillins, as well as 6-aminopenicillanic acid (6APA), could also bind to this target. Molecular dynamics simulations further confirmed that (5R)-pseudopenicillin and 6APA bind the target protein, in addition to (5S)-penicilloic acid. Thus, it is possible that these metabolites are bioactive, and, if stable in the environment, could be contaminants selective for antibiotic resistance. This could have considerable significance for environmental surveillance for antibiotics as a means to reduce antimicrobial resistance, because targeted mass spectrometry could be required for relevant metabolites as well as the native antibiotics.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Evolution under low antibiotic concentrations: a risk for the selection of Pseudomonas aeruginosa multidrug resistant mutants in nature
F. Sanz-Garcia, S. Hernando-Amado, J. L. Martinez·bioRxiv·Apr 21, 2021
- Discovery and chemical optimisation of a Potent, Bi-cyclic (Bicycle(R)) Antimicrobial Inhibitor of Escherichia coli PBP3
Catherine E Rowland, Hector Newman, … Michael J. Dawson·Communications BiologyPeer-reviewed·May 28, 2025
- Exploring PBP2a resistance in MRSA by comparison between molecular covalent docking and non-covalent docking
Ye-Qiang Cao, Yi Shi·bioRxiv·Feb 20, 2025
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA
Fredrick Mutie Musila, Grace Wairimu Gitau, … Patrisio Njiru Njeru·Journal of Biomolecular Structure and DynamicsPeer-reviewed·May 19, 2025
- Identification of potential carboxylic acid-containing drug candidate to design novel competitive NDM inhibitors: An in-silico approach comprising combined virtual screening and molecular dynamics simulation
Karthick Vasudevan, Soumya Basu, … Balaji Veeraraghavan·bioRxiv·Jul 5, 2021
- Cheminformatics identification of phenolics as modulators of penicillin binding protein (PBP) 2x of Streptococcus pneumoniae towards interventive antibacterial therapy
J. O. Aribisala, N. W. Sthebe, S. Sabiu·bioRxiv·Oct 2, 2023